Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Yebin Lu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100299411. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: 3 papers · 2018: 2 papers · 2019: 3 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper

Papers 17

  1. Menin regulates YBX1 nucleus translocation to boost the HKDC1 transcription and affects pancreatic cancer glycolysis. Co-author DOI 10.1016/j.isci.2025.113245↗
  2. Antitumor potentials of onco-microbial in Chinese patients with pancreatic cancer. Co-author DOI 10.1016/j.heliyon.2024.e40890↗
  3. Hypoxia promotes immune escape of pancreatic cancer cells by lncRNA NNT-AS1/METTL3-HuR-mediated ITGB1 m6A modification. Co-author DOI 10.1016/j.yexcr.2023.113764↗
  4. Correction: MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironment… Co-author DOI 10.1242/bio.059951↗
  5. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells. First author DOI 10.3389/fimmu.2023.1271603↗
  6. Corrigendum to "Long Noncoding RNA TUG1/miR-29c Axis Affects Cell Proliferation, Invasion, and Migration in Human Pancreatic Cancer". Co-author DOI 10.1155/2021/5150272↗
  7. Long noncoding RNA FEZF1-AS1 predicts poor prognosis and modulates pancreatic cancer cell proliferation and invasion through miR-142/HIF-1α and miR-133a/EGFR u… Co-author DOI 10.1002/jcp.28188↗
  8. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis. Last author DOI 10.1080/15476286.2019.1649585↗
  9. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. Last author DOI 10.3748/wjg.v25.i46.6728↗
  10. Long Noncoding RNA TUG1/miR-29c Axis Affects Cell Proliferation, Invasion, and Migration in Human Pancreatic Cancer. Co-author DOI 10.1155/2018/6857042↗
  11. LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451. Co-author DOI 10.3892/ijo.2018.4289↗
  12. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR. Co-author DOI 10.1002/jcb.25988↗
  13. Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells. Co-author DOI 10.1111/cas.13315↗
  14. MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironments. Co-author DOI 10.1242/bio.021774↗
  15. MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. First author DOI 10.2147/ott.s92758↗
  16. Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Co-author DOI 10.1007/s12032-010-9480-9↗
  17. Activation of the PI3K/Akt pathway mediates bone morphogenetic protein 2-induced invasion of pancreatic cancer cells Panc-1. Co-author DOI 10.1007/s12253-010-9307-1↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhenglin Ou · 4 shared papers, 2019–2023 · strength 0.65
  2. Xuejun Gong · 3 shared papers, 2017–2023 · strength 0.57
  3. Weijia Sun · 4 shared papers, 2011–2023 · strength 0.40
  4. Zhen Luo · 3 shared papers, 2019 · strength 0.38
  5. Shuai Liang · 2 shared papers, 2019–2024 · strength 0.33
  6. Wei Wei · 3 shared papers, 2017–2021 · strength 0.31
  7. Zhen Luo · 1 shared paper, 2023 · strength 0.26
  8. Shuai Zhu · 1 shared paper, 2023 · strength 0.26
  9. Chenming Ni · 1 shared paper, 2025 · strength 0.25
  10. Tianlin He · 1 shared paper, 2025 · strength 0.25
  11. Xiaohan Shi · 1 shared paper, 2025 · strength 0.25
  12. Peng Cheng · 1 shared paper, 2025 · strength 0.25
  13. Gang Jin · 1 shared paper, 2025 · strength 0.25
  14. Xitao Wang · 1 shared paper, 2023 · strength 0.22
  15. Yongchao Gao · 1 shared paper, 2024 · strength 0.22
  16. Wei Zhang · 1 shared paper, 2024 · strength 0.22
  17. Shuai Liang · 2 shared papers, 2018–2021 · strength 0.22
  18. Zhipeng Zhang · 2 shared papers, 2018 · strength 0.19
  19. Hongxi Chen · 2 shared papers, 2017–2018 · strength 0.18
  20. Ling Tang · 2 shared papers, 2017–2018 · strength 0.17
  21. Weijia Sun · 2 shared papers, 2011–2018 · strength 0.14
  22. Min Zhang · 1 shared paper, 2019 · strength 0.11
  23. Yixiong Li · 1 shared paper, 2019 · strength 0.11
  24. Tong Han · 1 shared paper, 2019 · strength 0.11
  25. Xitao Wang · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.